What Moderna (MRNA)'s Expedited Flu Vaccine Review And Institutional Support Means For Shareholders
Moderna, Inc. recently participated in the 5th LNP Formulation & Process Development Summit in Boston and scheduled a May 1, ...
Moderna: The Case For Staying On The Sidelines
FDA reversal, patent relief, and mRESVIA risks show a commoditized market and lofty $20B valuation. See more here.
What If the FDA Vaccine Chief Was Required to Be Someone with a Background in Vaccines?
Just imagine, if the person responsible for evaluating vaccines at the FDA was required to have experience in that field ...
Ophthalmologist is front-runner for next FDA vaccine chief, sources say
Dr. Houman Hemmati, an ophthalmologist critical of the government’s Covid vaccine response, is the front-runner for the role ...
Your guide to who’s who in the MAHA movement
While Paltrow hasn't endorsed MAHA, she told Vanity Fair last year that she's “very fascinated” by Kennedy's movement. Some ...
Trump officials consider ophthalmologist Hemmati for top vaccine post, reports say
WASHINGTON, April 13 (Reuters) - The Trump administration is considering appointing Houman Hemmati, an ophthalmologist and a ...
BioSpace
Deep dive: Checking in with the FDA
The FDA in 2025 was marked by a constant state of turmoil, from a massive workforce reduction that cut some 3,500 staffers ...
MIT Technology Review
The Download: how humans make decisions, and Moderna’s “vaccine” word games
Plus: Sam Altman's home has been attacked twice in two days. This is today's edition of The Download, our weekday newsletter ...
Santé log
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study. First head-to-head, double-blind, randomized phase 4 study powered to ...